logo
Select company
Select metric
23.73%Goodwill & Intangibles to Assets Ratio
VS
Market
73
Sector
76
Industry
92
History
43
$ 5.45Close
$ 2.42 - $ 5.73 52-Week Range
Ticker Information

Ticker

PBYI

Company Name

PUMA BIOTECHNOLOGY INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PUMA BIOTECHNOLOGY INC - Goodwill & Intangibles to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PBYI - Intang. to Assets Historical data
DateTotal AssetsGoodwill and IntangiblesGoodwill & Intangibles to Assets Ratio
6/30/2025$ 194.92M$ 46.26M23.73%
3/31/2025$ 196.18M$ 48.7M24.82%
12/31/2024$ 213.33M$ 51.13M23.97%
9/30/2024$ 220.72M$ 53.57M24.27%
6/30/2024$ 205M$ 56M27.32%
3/31/2024$ 214.15M$ 58.44M27.29%
12/31/2023$ 230.53M$ 60.87M26.41%
9/30/2023$ 203.6M$ 63.3M31.09%
6/30/2023$ 200.49M$ 65.74M32.79%
3/31/2023$ 196.26M$ 68.17M34.74%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PUMA BIOTECHNOLOGY INC's latest trailing twelve months (TTM) Intang. to Assets stands at 29.1%.
  • Over the past 5 years, PUMA BIOTECHNOLOGY INC's average Intang. to Assets has been 28.8%.
  • The median Intang. to Assets for PUMA BIOTECHNOLOGY INC during this period was 29.14%
  • PUMA BIOTECHNOLOGY INC reached its highest Intang. to Assets over the past 5 years at 34.74%.
  • The lowest Intang. to Assets recorded by PUMA BIOTECHNOLOGY INC in the same timeframe 23.73%

PUMA BIOTECHNOLOGY INC's Intang. to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Intang. to Assets Benchmarks
CompanyIntang. to Assets
HRTX : HERON THERAPEUTICS INC 0%VNDA : VANDA PHARMACEUTICALS INC 17.7%MGNX : MACROGENICS INC 0%ENTA : ENANTA PHARMACEUTICALS INC 0%AGEN : AGENUS INC 14.74%ALEC : ALECTOR INC 0%ATRA : ATARA BIOTHERAPEUTICS INC 0%SGMO : SANGAMO THERAPEUTICS INC 0%CHRS : COHERUS ONCOLOGY INC 11.9%GLUE : MONTE ROSA THERAPEUTICS INC 0%

Definition of Goodwill & Intangibles to Assets Ratio

[Calculation] The [Intangibles] to [Assets] ratio is used as a company valuation factor by investors. Goodwill & Intangibles represent hard-to-value assets like a company’s brand name, solid customer relations, intellectual property, etc.
Intangibles / Assets
(=) Intang. to Assets
Intang. to Assets for PUMA BIOTECHNOLOGY INC is calculated as follows: Intangibles [ $ 76.14M ] / Assets [ $ 261.69M ]
(=) Intang. to Assets [ 29.1% ]

PBYI - Goodwill & Intangibles to Assets Ratio, Last 5 years

23.73%

Minimum

Jun 30, 2025

34.74%

Maximum

Mar 31, 2023

28.8%

Average

29.14%

Median

Intang. to Assets Benchmark Analysis

The chart above depicts the distribution of Intang. to Assets for companies in the Total Stock Market. The average Intang. to Assets of the companies is 3.99% with a standard deviation of 6.1%.
The following table provides additional summary stats:
Intang. to Assets in the Market:
filtered constituents3.24K
min0%
max23.21%
average3.99%
median0.52%
std6.1%